VistaGen Therapeutics Inc (VTGN)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.01B
EV to revenue ratio (TTM)
76.82
EV to ebitda
-0.19
Financial Performance
Revenue (TTM)
$0.00B
Gross profit (TTM)
$0.00B
EBITDA
-$0.07B
Profitability
Operating margin (TTM)
-904.00%
Profit margin
<0.01%
Return on assets (TTM)
-83.20%
Return on equity (TTM)
-166.50%
Per Share Metrics
Revenue per share (TTM)
$0.06
EPS
-$1.66
Diluted EPS (TTM)
-$1.66
Book value
$0.55
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
0
Price to sales ratio (TTM)
3.27
Price to book ratio (TTM)
0.30
Growth
Quarterly earnings growth (YoY)
505.00%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
0
Buy
0
Hold
4
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.47